Objective: To evaluate the relation between benzodiazepine use and cognitiv
e function among community-dwelling elderly.
Methods This prospective cohort study included 2765 self-reporting subjects
from the Duke Established Populations for Epidemiologic Studies of the Eld
erly. The subjects were cognitively intact at baseline (1986-1987) and aliv
e at follow-up data collection 3 years later. Cognitive function was assess
ed with the Short Portable Mental Status Questionnaire (unimpaired versus i
mpaired and change in score) and on the basis of the number of errors on th
e individual domains of the Orientation-Memory-Concentration Test. Benzodia
zepine use was determined during in-home interviews and classified by dose,
half-life, and duration. Covariates included demographic characteristics,
health status, and health behaviors.
Results: After control for covariates, current users of benzodiazepine made
more errors on the memory test (beta coefficient, 0.35; 95% confidence int
erval [CI], 0.10 to 0.61) than nonusers. Further assessment of the negative
effects on memory among current users suggested a dose response in which u
sers taking the recommended or higher dose made more errors (beta coefficie
nt, 0.57; 95% CT, 0.26 to 0.88) and a duration response in which long-term
users made more errors (bt-ta coefficient, 0.39; 95% CI, 0.05 to 0.73) than
nonusers. Users of agents with long half-lives and users of agents with sh
ort half-lives both had increased memory impairment (beta coefficient, 0.32
; 95% CI, 0.01 to 0.64 and beta coefficient, 0.38; 95% CI, 0.02 to 0.75, re
spectively) relative to nonusers. Previous benzodiazepine use was unrelated
to memory problems, and current and previous benzodiazepine use was unrela
ted to level of cognitive functioning as measured with the other 4 tests.
Conclusions: The results suggested that current benzodiazepine use, especia
lly in recommended or higher doses, is associated with worse memory among c
ommunity-dwelling elderly.